Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification.
about
Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classificationAcute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous diseasePure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cellsAcute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AML.The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification.Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia.Standards and impact of hematopathology in myelodysplastic syndromes (MDS).Soft tissue tumors of uncertain origin.Extraskeletal myxoid chondrosarcoma: a review of 23 patients treated at a single referral center with long-term follow-up.Extraskeletal myxoid chondrosarcoma presenting as an intradural spinal mass: report of a rare clinical presentation with an emphasis on differential diagnostic considerations.Importance of classical morphology in the diagnosis of myelodysplastic syndrome.Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.Atypical Ewing sarcoma breakpoint region 1 fluorescence in-situ hybridization signal patterns in bone and soft tissue tumours: diagnostic experience with 135 cases.Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts.Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs): development of acute erythroleukemia may not influence assessment of treatment response.Acute myeloid leukemia with expanded erythropoiesis.Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
P2860
Q28269007-765B88E4-2852-4755-B6F3-35E3FBF8F52BQ28282623-79A1D582-31A4-4E67-B265-6F7A00A76104Q34151502-9A5CFB7A-8DB9-41CB-AF46-2F2B168F9C4CQ34609393-F0E6C845-12D1-42B3-8E43-0C04F901F174Q35193722-372893A1-B2BA-41E5-83D0-91902092F59AQ36109515-BC79CBFC-03FE-4D4E-B2FC-1DF448DF8E2BQ36279945-5EFA9D58-6BBC-4A04-86BB-5FA3B32E23F8Q37592412-8D2B659D-1F5F-4B1D-AACF-99190D7BDB7EQ37840934-7891D1B8-CF94-4665-B411-9E197D9827ABQ37993931-0939FE1C-E5FB-4D78-9118-F2C41D3C31DBQ38017129-D24F8A9B-A318-4692-B8B0-66FC744D8D6CQ38311097-F292DB37-AB5D-43AF-BB9F-F3A76E2D3B92Q38471249-A94A1B32-3E49-4F09-800D-F2D0A20527E3Q38827726-5BDEBBC7-961F-4D9E-B2EF-4349D8D10CEBQ38888453-FAB53CE4-8B88-4406-939D-0C85245CB83AQ39575152-64C65DFB-E00E-463D-BC18-96861CA886EBQ41465409-E950FB34-5FFE-4DA1-955D-D31A627F26CEQ43191865-9E10281A-2253-457C-888E-7C69A8E5FAC7Q46088787-85E79B1B-A958-4FF2-80C4-AC615790C2F1
P2860
Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Erythroid-predominant myelodys ...... superior risk stratification.
@en
Erythroid-predominant myelodys ...... superior risk stratification.
@nl
type
label
Erythroid-predominant myelodys ...... superior risk stratification.
@en
Erythroid-predominant myelodys ...... superior risk stratification.
@nl
prefLabel
Erythroid-predominant myelodys ...... superior risk stratification.
@en
Erythroid-predominant myelodys ...... superior risk stratification.
@nl
P2093
P2860
P1433
P1476
Erythroid-predominant myelodys ...... superior risk stratification.
@en
P2093
Bruce A Woda
Guilin Tang
Oluwole Fadare
Robert P Hasserjian
Suyang Hao
P2860
P2888
P304
P356
10.1038/MODPATHOL.2008.114
P577
2008-09-12T00:00:00Z